S-Nitrosomercaptoethanol
Grundinformationen
- CAS
67616-44-8- Standard-SMILES
O=NSCCO- InChIKey
AVGNNQMFRRYDBY-UHFFFAOYSA-N- Summenformel
- C2H5NO2S
- Durchschnittliche Molmasse
- 107,13 g/mol
- Monoisotopische Masse
- 107,00409958
Überblick
A sulfur-containing alkyl thionitrite that is a nitric oxide donor. It is an anti-infective agent and inhibits Bacillus cereus spore outgrowth.
Namen und Bezeichner
- Bevorzugter Name
- S-Nitrosomercaptoethanol
- IUPAC
- 2-nitrososulfanylethanol
- Englischer Name
- S-nitrosomercaptoethanol
- Summenformel
- C2H5NO2S
- Molmasse
- 107.13
Namen und Synonyme
S-Nitrosomercaptoethanol2-Mercaptoethanol thionitriteCCRIS 209667616-44-8Thionitrous acid, S-(2-hydroxyethyl) esterDTXSID00217934RefChem:180707DTXCID501404252-(Nitrososulfanyl)ethan-1-olS-nitroso-2-mercaptoethanolSCHEMBL319965G52557EEA6
Weitere Namen anzeigen
Thionitrous acid (HNOS), S-(2-hydroxyethyl) ester
Datenbank-Bezeichner
- CAS
67616-44-8- PubChem CID
- 108022
- DTXSID
DTXSID00217934- UNII
- G52557EEA6
- Nikkaji
- J630.100B
Eigenschaften
Berechnete Struktureigenschaften
- XLogP
- -0,5
- Polarare Oberfläche (TPSA)
- 75 Ų
- H-Brücken-Donoren
- 1
- H-Brücken-Akzeptoren
- 4
- Frei drehbare Bindungen
- 2
- Schwere Atome
- 6
- Formalladung
- 0
- Komplexität
- 40,5
Physikochemische Eigenschaften
- Siedepunkt
- 215.6 · 215.6±42.0 °C(Predicted)
- Dichte
- 1.37 · 1.37±0.1 g/cm3(Predicted)
- pka
- 13.82 · 13.82±0.10(Predicted)
Chemie und Industrie
Pharmakologische Informationen
MeSH Pharmacological Classification
Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection.
Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system.
A diverse group of agents, with unique chemical structures and biochemical requirements, which generate NITRIC OXIDE. These compounds have been used in the treatment of cardiovascular diseases and the management of acute myocardial infarction, acute and chronic congestive heart failure, and surgical control of blood pressure. (Adv Pharmacol 1995;34:361-81)
Zugehörige Reaktionen
0
Keine Reaktionsaufzeichnungen unter den aktuellen Filterkriterien.
Notizen zur Verbindung
Wird geladen…